Who invested in OrsoBio?
OrsoBio's investors include Eli Lilly, Samsara BioCapital and Longitude Capital.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$67Mraised across 1 round since 2024, from 1 source
Source recordedSEC filing: $40M sold, first sale Aug 2024
OrsoBio's investors include Eli Lilly, Samsara BioCapital and Longitude Capital.
OrsoBio has raised $67M across 1 round since 2024.
OrsoBio's most recent round was a Series B of $67M in Sept 2024.
Its most recent round, $67M in Sept 2024, is also its largest on record.
OrsoBio's first round on record, in Sept 2024, was backed by Eli Lilly, Samsara BioCapital and Longitude Capital.
OrsoBio's latest named round is a Series B, in Sept 2024.
OrsoBio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.